Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Principal Open-Label Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Amyloid Levels Determined Post-Mortem

NCT01165554 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT01165554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01165554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Principal Open-Label Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Amyloid Levels Determined Post-Mortem
Lead sponsor
GE Healthcare
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2010
Completion date
November 30, 2011
Enrollment
203 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain fibrillarab levels